The impact of mitochondrial deficiencies in neuromuscular diseases J Cantó-Santos, JM Grau-Junyent, G Garrabou Antioxidants 9 (10), 964, 2020 | 38 | 2020 |
The Genetic Landscape of Mitochondrial Diseases in Spain: A Nationwide Call JMRA Marcello Bellusci, Abraham J Paredes-Fuentes, Eduardo Ruiz-Pesini ... Genes 12 (1590), 1-12, 2021 | 17* | 2021 |
Systematic collaborative reanalysis of genomic data improves diagnostic yield in neurologic rare diseases G Bullich, L Matalonga, M Pujadas, A Papakonstantinou, D Piscia, ... The Journal of molecular diagnostics 24 (5), 529-542, 2022 | 16 | 2022 |
Mitochondrial toxicogenomics for antiretroviral management: HIV post-exposure prophylaxis in uninfected patients M Bañó, C Morén, S Barroso, DL Juárez, M Guitart-Mampel, ... Frontiers in Genetics 11, 497, 2020 | 16 | 2020 |
CIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative J Luque, I Mendes, B Gomez, B Morte, M López de Heredia, E Herreras, ... Clinical Genetics 101 (5-6), 481-493, 2022 | 14 | 2022 |
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature NL Guerra, A Matas-García, L Serra-García, D Morgado-Carrasco, ... Autoimmunity Reviews 22 (8), 103375, 2023 | 11 | 2023 |
Mitochondrial dysfunction: a common hallmark underlying comorbidity between sIBM and other degenerative and age-related diseases M Catalan-Garcia, FJ García-García, PJ Moreno-Lozano, ... Journal of clinical medicine 9 (5), 1446, 2020 | 11 | 2020 |
Essential role for albumin in preserving liver cells from TNFα‐induced mitochondrial injury M Duran‐Güell, G Garrabou, R Flores‐Costa, M Casulleras, ... The FASEB Journal 37 (3), e22817, 2023 | 9 | 2023 |
Unravelling inclusion body myositis using apatient-derivedfibroblast model J Cantó-Santos, L Valls-Roca, E Tobías, FJ García-García, ... Journal of Cachexia, Sarcopenia and Muscle, 2023 | 6 | 2023 |
Bioenergetic and Autophagic Characterization of Skin Fibroblasts from C9orf72 Patients MI Alvarez-Mora, G Garrabou, T Barcos, F Garcia-Garcia, R Grillo-Risco, ... Antioxidants 11 (6), 1129, 2022 | 6 | 2022 |
Integrated multi-omics analysis for inferring molecular players in inclusion body myositis J Cantó-Santos, L Valls-Roca, E Tobías, C Oliva, FJ García-García, ... Antioxidants 12 (8), 1639, 2023 | 3 | 2023 |
Fibroblast phenylalanine concentration as a surrogate biomarker of cellular number C Oliva, A Arias, M Ruiz, A Pujol, G Garrabou, J Canto-Santos, R Urreizti, ... Journal of Chromatography B 1226, 123787, 2023 | 3 | 2023 |
Neuronal induction and bioenergetics characterization of human forearm adipose stem cells from Parkinson’s disease patients and healthy controls I González-Casacuberta, D Vilas, C Pont-Sunyer, E Tobías, ... Plos one 17 (3), e0265256, 2022 | 3 | 2022 |
Metabolic, Mitochondrial, and Inflammatory Effects of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate in Asymptomatic Antiretroviral-Naïve People with HIV S Barroso, M Guitart-Mampel, FJ García-García, J Cantó-Santos, ... International Journal of Molecular Sciences 25 (15), 8418, 2024 | | 2024 |
Validation of fibroblast model from Kearns Sayre's patients by transcriptomic and functional approaches L Valls-Roca, A Vilaseca-Capel, J Canto-Santos, E Tobias, ... EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 54, 2024 | | 2024 |
Exploration of SUMO2/3 Expression Levels and Autophagy Process in Fragile X-Associated Tremor/Ataxia Syndrome: Addressing Study Limitations and Insights for Future Research MI Alvarez-Mora, G Garrabou, L Molina-Porcel, R Grillo-Risco, ... Cells 12 (19), 2364, 2023 | | 2023 |
Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir A Ortiz-Gracia, M Ríos, E Tobías, A Noguera-Julian, FJ García-García, ... Archives of Disease in Childhood 107 (7), 686-691, 2022 | | 2022 |
Effect of clostridium toxins on intestinal epithelial cell morphology J Cantó Santos Universitat Politècnica de València, 2017 | | 2017 |
Dermatomyositis Triggered by Immune Checkpoint Inhibitors. Three Additional Cases and a Review of the Literature N López-Guerra, A Matas-Garcia, L Serra-García, D Morgado-Carrasco, ... | | |